Table 1 Patient characteristics
Characteristic | n (out of 178) | Percentage |
|---|---|---|
Gender | ||
Male | 76 | 42.7% |
Female | 102 | 57.3% |
Age (years) | ||
Median (Q1–Q3) | 61.0 (52.0–71.0) | |
Mean (s.d.) | 60.6 (14.8) | |
≥70 years old | 50 | 28.1% |
Smoking | ||
Never | 89 | 50.6% |
Former | 43 | 24.4% |
Current | 20 | 11.4% |
Unknown | 24 | 13.6% |
Comorbidities | ||
Hypertension | 65 | 36.5% |
Diabetes | 35 | 19.7% |
Dyslipidemia | 16 | 9.0% |
Cardiac disease (ischemic/other) | 9/21 | 5.1%/11.8% |
Chronic kidney disease | 10 | 5.6% |
Autoimmune disease | 9 | 5.1% |
BMI | ||
Median (Q1–Q3) | 25.0 (22.0–28.0) | |
Mean (s.d.) | 25.0 (4.9) | |
<18.5 | 12 | 7.4% |
18.5–25 | 64 | 39.3% |
25–30 | 62 | 38.0% |
≥30 | 25 | 15.3% |
History of cancer | ||
Solid tumors | 156a | |
Breast | 32 | 20.5% |
Gynecological | 23 | 14.7% |
Head and neck | 22 | 14.1% |
Gastrointestinal | 21 | 13.5% |
Genitourinary | 20 | 12.8% |
Thoracic | 17 | 10.9% |
Dermatology | 11 | 7.1% |
Others (endocrine, CNS, ACUP) | 10 | 6.4% |
Hematological malignancies | 30a | |
Mature B cell neoplasm/myeloma | 15 | 50.0% |
Acute myeloid leukemia | 8 | 26.7% |
Hodgkin lymphoma | 4 | 13.3% |
Others | 3 | 10.0% |
Disease status | ||
Remission/curative intent | 70 | 39.3% |
Active/advanced disease | 108 | 60.7% |
PS at last oncological visit | ||
0/1 | 129 | 72.9% |
≥2 | 48 | 27.1% |
Systemic treatments in the past 3 months | ||
Yes | 117 | 66.9% |
Cytotoxic chemotherapy | 66 | 37.1% |
Target therapy | 30 | 16.9% |
Hormone therapy | 16 | 10.3% |
Immune checkpoint inhibitor | 19 | 10.7% |
